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Letter to the Editor
A thorough MECP2 mutation analysis
To the Editor:
With great interest we have read the short
report of Takahashi et al. entitled, Skewed X
chromosome inactivation failed to explain the
normal phenotype of a carrier female with
MECP2 mutation resulting in Rett syndrome’.
The report describes a novel missense MECP2
mutation (P.A447T) detected in a girl with Rett
syndrome and her asymptomatic carrier mother.
Results from X-chromosome inactivation (XCI)
studies performed on DNA from the mother
showedanon-randomXCIpattern.Furtherinves-
tigation showed that the mother’s predominantly
active X-chromosome harbours the mutant allele.
The authors speculate how these results could be
correlated to the carrier mother’s normal pheno-
type and her daughter’s Rett phenotype.
We consider that several relevant investigations
are missing – especially to justify the title of this
report. The authors need to address further
genetic aspects before proposing a functional
pathogenic nature of A447T.
We lack information regarding the MECP2
mutation analysis. Was the Rett patient tested
according to current knowledge about MECP2
mutations including testing for mutations in exon
1 or large deletions/duplications in the MECP2
gene? (1–4) If present, it could explain the Rett
syndrome phenotype and then A447T would
most likely be a rare variation.
Are there any relatives in this family (siblings to
the patient, to her mother or grandparents) who
could be tested? Finding A447T in other family
members (especially males) with normal pheno-
type would be a strong indication of a rare
variation.
What do protein substitution programs pre-
dict? Is A447T predicted to be a tolerated amino
acids shift in MeCP2?
It has to be taken into consideration that no
other pathogenic missense mutations in the C-
terminal of MeCP2 have been published in a Rett
patient.
K Ravn
JB Nielsen
Kennedy Center, Center for Rett syndrome,
Glostrup, Denmark
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